tiprankstipranks
Astellas’ New Cancer Therapy Gains Japan Approval
PremiumCompany AnnouncementsAstellas’ New Cancer Therapy Gains Japan Approval
2M ago
Astellas Wins EU Approval for Advanced Cancer Drug
Premium
Company Announcements
Astellas Wins EU Approval for Advanced Cancer Drug
2M ago
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
Premium
The Fly
Bicycle says 45% of patients respond to bladder cancer drug, EN reports
2M ago
ALPMF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsALPMF Upcoming Earnings Report: What to Expect?
4M ago
Astellas Nears EU Approval for Groundbreaking Cancer Drug
Premium
Company Announcements
Astellas Nears EU Approval for Groundbreaking Cancer Drug
4M ago
Astellas’ New Therapy Set to Transform Bladder Cancer Treatment
Premium
Company Announcements
Astellas’ New Therapy Set to Transform Bladder Cancer Treatment
4M ago
CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration
PremiumThe FlyCytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration
8M ago
FDA grants orphan drug, pediatric exclusivities for Cresemba for IA, IM
Premium
The Fly
FDA grants orphan drug, pediatric exclusivities for Cresemba for IA, IM
9M ago
Seagen, Astellas and Merck announce FDA grants priority review to Padcev BLA
Premium
The Fly
Seagen, Astellas and Merck announce FDA grants priority review to Padcev BLA
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100